A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)

1. Martinon-Torres, F.
2. Wysocki, J.
3. Szenborn, L.
4. Carmona-Martinez, A.
5. Poder, A.
6. Dagan, R.
7. Richmond, P.
8. Gilbert, C.
9. Trudel, M.-C.
10. Flores, S.
11. Lupinacci, R.
12. McFetridge, R.
13. Wiedmann, R.T.
14. Chen, Q.
15. Gerrits, H.
16. Banniettis, N.
17. Musey, L.
18. Bickham, K.
19. Kaminski, J.